Literature DB >> 3105303

Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?

S Sherry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3105303     DOI: 10.1016/0002-9149(87)91139-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

1.  Purification and characterization of a fibrinolytic enzyme produced from Bacillus sp. strain CK 11-4 screened from Chungkook-Jang.

Authors:  W Kim; K Choi; Y Kim; H Park; J Choi; Y Lee; H Oh; I Kwon; S Lee
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

Review 2.  Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.

Authors:  H Ferres
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  [Antibody mediated thrombolysis. A new therapeutic principle].

Authors:  C Bode; W Kübler
Journal:  Klin Wochenschr       Date:  1989-07-03

4.  Thrombolytic therapy for central retinal vein occlusion: results of a pilot study.

Authors:  M J Elman
Journal:  Trans Am Ophthalmol Soc       Date:  1996
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.